The decreased expression of RKIP in breast cancer cells and prostate cancer cells inhibits chemotherapy-induced apoptosis, whereas the restoration of RKIP expression can increase the sensitivity of the tumor cells to chemotherapy drugs[15]. The gene discussed is PEBP1; the disease is prostate carcinoma.